Perfluorinated acids and hypothyroxinemia in pregnant women

Environmental Research

Volumn 111, Issue 4, 2011, Pages 559-564

  Chan, Emily ^a   Burstyn, Igor ^a,b   Cherry, Nicola ^a   Bamforth, Fiona ^a   Martin, Jonathan W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DREXEL UNIVERSITY   (United States)

Author keywords

Case control study; Epidemiology; Perfluorinated compounds; Pregnancy; Thyroid

Indexed keywords

PERFLUORO COMPOUND; PERFLUOROHEXANESULFONATE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

BLOOD; EPIDEMIOLOGY; HEALTH RISK; HOMEOSTASIS; HORMONE; POLLUTION EXPOSURE; PREGNANCY;

ADULT; ARTICLE; BLOOD EXAMINATION; CANADA; CONTROLLED STUDY; DISORDERS OF HORMONE METABOLISM; ENVIRONMENTAL EXPOSURE; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPOTHYROXINEMIA; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL;

ADULT; ALKANESULFONIC ACIDS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; HYPOTHYROIDISM; MATERNAL EXPOSURE; MIDDLE AGED; OCTANOIC ACIDS; PREGNANCY; SULFONIC ACIDS; THYROXINE; YOUNG ADULT;

ALBERTA; CANADA; EDMONTON;

ANIMALIA;

EID: 79955105245     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2011.01.011     Document Type: Article

References (51)

1. Alexander B.H., et al. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup. Environ. Med. 2003, 60:722-729.
2. Apelberg B.J., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 2007, 115:1670-1676.
3. Benskin J.P., et al. Simultaneous characterization of perfluoroalkyl carboxylate, sulfonate, and sulfonamide isomers by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 79:6455-6464.
4. Calafat A.M., et al. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115:1596-1602.
5. Casey B.M., et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet. Gynecol. 2007, 109:1129-1135.
6. Chan E., et al. Endogenous high-performance liquid chromatography/tandem mass spectrometry interferences and the case of perfluorohexane sulfonate (PFHxS) in human serum; are we overestimating exposure?. Rapid Commun. Mass Spectrom. 2009, 23:1405-1410.
7. Chang S.C., et al. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 2008, 243:330-339.
8. Chang S.C., et al. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 2007, 234:21-33.
9. Cleary-Goldman J., et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet. Gynecol. 2008, 112:85-92.
10. Dallaire R., et al. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ. Health Perspect. 2009, 117:1380-1386.
11. Emmett E.A., et al. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J. Occup. Environ. Med. 2006, 48:771-779.
12. Fei C., et al. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ. Health Perspect. 2007, 115:1677-1682.
13. Fei C., et al. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am. J. Epidemiol. 2008, 168:66-72.
14. Fuentes S., et al. Interactions in developmental toxicology: concurrent exposure to perfluorooctane sulfonate (PFOS) and stress in pregnant mice. Toxicol. Lett. 2006, 164:81-89.
15. Gabos S., Cheperdak, Z.M.L., Kinniburgh D., Lee B., Hrudey S., Le C., Li X.F., Mandal R., Martin J.W., Schopflocher D., 2008. Chemical biomonitoring in serum of pregnant women in Alberta (2005); Influence of Age, Location and Seasonality Alberta Health and Wellness, p.143. http://www.health.alberta.ca/documents/Chemical-Biomonitoring-2008.pdf.
16. Giesy J.P., Kannan K. Perfluorochemical surfactants in the environment. Environ. Sci. Technol. 2002, 36:146A-152A.
17. Glinoer D. Pregnancy and iodine. Thyroid 2001, 11:471-481.
18. Gutshall D.M., et al. Effect of thyroxine supplementation on the response to perfluoro-n-decanoic acid (PFDA) in rats. J. Toxicol. Environ. Health 1988, 24:491-498.
19. Gutshall D.M., et al. Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. J. Toxicol. Environ. Health 1989, 28:53-65.
20. Hamm M.P., Cherry N.M., Chan E., Martin J.W., Burstyn I. Maternal exposure to perfluorinated acids and fetal growth. Journal of Exposure Analysis and Environ. Epidemiol. 2010, 20:589-597. Available from: 〈http://dx.doi.org/10.1038/jes.2009.57〉.
21. Hamm M.P., et al. The impact of isolated maternal hypothyroxinemia on perinatal morbidity. J. Obstet. Gynaecol. Can. 2009, 31:1015-1021.
22. Hansen K.J., et al. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 2001, 35:766-770.
23. Inoue K., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ. Health Perspect. 2004, 112:1204-1207.
24. Kuklenyik Z., et al. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ. Sci. Technol. 2004, 38:3698-3704.
25. Langley A.E., Pilcher G.D. Thyroid, bradycardic and hypothermic effects of perfluoro-n-decanoic acid in rats. J. Toxicol. Environ. Health 1985, 15:485-491.
26. Larsen P.D., DeLallo L. Cerebrospinal fluid transthyretin in the neonate and blood-cerebrospinal fluid barrier permeability. Ann. Neurol. 1989, 25:628-630.
27. Lau C., et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
28. Lau C., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol. Sci. 2003, 74:382-392.
29. Luebker D.J., et al. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 2005, 215:149-169.
30. Martin M.T., et al. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol. Sci. 2007, 97:595-613.
31. Melzer D., et al. Association between serum perfluoroctanoic acid (PFOA) and thyroid disease in the NHANES study. Environ. Health Perspect 2010.
32. Monroy R., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ. Res. 2008, 108:56-62.
33. Olsen G.W., et al. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J. Occup. Environ. Med. 1999, 41:799-806.
34. Olsen G.W., et al. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ. Sci. Technol. 2008, 42:4989-4995.
35. Olsen G.W., et al. Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere 2007, 68:105-111.
36. Peck P.D., Calafat N.B.A.M., Sjodin A., Cowan L.D. Effect of persistent organic pollutants on thyroid hormone levels during pregnancy [abstract]. Am. J. Epidemiol. 2008, 167:S103.
37. Pop V.J., et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin. Endocrinol. (Oxf) 2003, 59:282-288.
38. Pop V.J., et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin. Endocrinol. (Oxf) 1999, 50:149-155.
39. Reuss M.L., et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N. Engl. J. Med. 1996, 334:821-827.
40. Savitz D.A. Biomarkers of perfluorinated chemicals and birth weight. Environ. Health Perspect. 2007, 115:A528-A529.
41. Seacat A.M., et al. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 2003, 183:117-131.
42. Seacat A.M., et al. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 2002, 68:249-264.
43. Sohlenius A.K., et al. The effects of perfluoro-octanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice. Biochem. J. 1992, 285(Pt 3):779-783.
44. Sohlenius A.K., et al. Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver. Pharmacol. Toxicol. 1993, 72:90-93.
45. Steenland K., et al. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ. Health Perspect 2010.
46. Stockholm Convention, POPs Review Committee (POPRC)-Listing New Chemicals.
47. Thibodeaux J.R., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol. Sci. 2003, 74:369-381.
48. Washino N., et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ. Health Perspect. 2009, 117:660-667.
49. Weiss J.M., et al. Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol. Sci. 2009, 109:206-216.
50. Yeung L.W., et al. Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. Environ. Sci. Technol. 2006, 40:715-720.
51. Yu W.G., et al. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ. Toxicol. Chem. 2009, 28:990-996.